CRBP

CRBP

USD

Corbus Pharmaceuticals Holdings Inc. Common Stock

$11.250-0.880 (-7.255%)

Prix en Temps Réel

Healthcare
Biotechnologie
États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$12.130

Haut

$12.168

Bas

$11.230

Volume

0.56M

Fondamentaux de l'Entreprise

Capitalisation Boursière

191.2M

Industrie

Biotechnologie

Pays

United States

Statistiques de Trading

Volume Moyen

0.27M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $4.64Actuel $11.250Haut $20.77

Actualités Connexes

GlobeNewswire

Corbus Pharmaceuticals Announces Pricing of Public Offering

NORWOOD, Mass., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced the pricing of an underwritten public

Voir plus
Corbus Pharmaceuticals Announces Pricing of Public Offering
GlobeNewswire

Corbus Pharmaceuticals Announces Proposed Public Offering

NORWOOD, Mass., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) ("Corbus" or the "Company"), an oncology and obesity company, today announced that it plans to offer and sell shares

Voir plus
Corbus Pharmaceuticals Announces Proposed Public Offering
GlobeNewswire

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025

Data to be presented for 167 enrolled participants of which 122 were evaluable for efficacy Company to host HNSCC KOL event to review and discuss data NORWOOD, Mass., Oct. 14, 2025

Voir plus
Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025

Restez Informé

Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.